152 related articles for article (PubMed ID: 38900726)
1. Modeling the economic burden of postpartum hemorrhage due to substandard uterotonics in Ghana.
Bautista K; Lee YA; Higgins CR; Procter P; Rushwan S; Baidoo A; Issah K; Fofie CO; Gülmezoglu AM; Chinery L; Ozawa S
PLOS Glob Public Health; 2024; 4(6):e0003181. PubMed ID: 38900726
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness and budget impact of heat-stable carbetocin compared to oxytocin and misoprostol for the prevention of postpartum hemorrhage (PPH) in women giving birth in India.
Cook JR; Saxena K; Taylor C; Jacobs JL
BMC Health Serv Res; 2023 Mar; 23(1):267. PubMed ID: 36932411
[TBL] [Abstract][Full Text] [Related]
3. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Papadopoulou A; Man R; Athanasopoulos N; Tobias A; Price MJ; Williams MJ; Diaz V; Pasquale J; Chamillard M; Widmer M; Tunçalp Ö; Hofmeyr GJ; Althabe F; Gülmezoglu AM; Vogel JP; Oladapo OT; Coomarasamy A
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011689. PubMed ID: 30569545
[TBL] [Abstract][Full Text] [Related]
4. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
Parry Smith WR; Papadopoulou A; Thomas E; Tobias A; Price MJ; Meher S; Alfirevic Z; Weeks AD; Hofmeyr GJ; Gülmezoglu AM; Widmer M; Oladapo OT; Vogel JP; Althabe F; Coomarasamy A; Gallos ID
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD012754. PubMed ID: 33232518
[TBL] [Abstract][Full Text] [Related]
5. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
Gallos ID; Williams HM; Price MJ; Merriel A; Gee H; Lissauer D; Moorthy V; Tobias A; Deeks JJ; Widmer M; Tunçalp Ö; Gülmezoglu AM; Hofmeyr GJ; Coomarasamy A
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011689. PubMed ID: 29693726
[TBL] [Abstract][Full Text] [Related]
6. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis.
Gallos I; Williams H; Price M; Pickering K; Merriel A; Tobias A; Lissauer D; Gee H; Tunçalp Ö; Gyte G; Moorthy V; Roberts T; Deeks J; Hofmeyr J; Gülmezoglu M; Coomarasamy A
Health Technol Assess; 2019 Feb; 23(9):1-356. PubMed ID: 30821683
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
Westhoff G; Cotter AM; Tolosa JE
Cochrane Database Syst Rev; 2013 Oct; (10):CD001808. PubMed ID: 24173606
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic oxytocin for the third stage of labour to prevent postpartum haemorrhage.
Salati JA; Leathersich SJ; Williams MJ; Cuthbert A; Tolosa JE
Cochrane Database Syst Rev; 2019 Apr; 4(4):CD001808. PubMed ID: 31032882
[TBL] [Abstract][Full Text] [Related]
9. Current research on carbetocin and implications for prevention of postpartum haemorrhage.
Theunissen FJ; Chinery L; Pujar YV
Reprod Health; 2018 Jun; 15(Suppl 1):94. PubMed ID: 29945640
[TBL] [Abstract][Full Text] [Related]
10. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Apr; (4):CD005457. PubMed ID: 22513931
[TBL] [Abstract][Full Text] [Related]
11. Postpartum haemorrhage management, risks, and maternal outcomes: findings from the World Health Organization Multicountry Survey on Maternal and Newborn Health.
Sheldon WR; Blum J; Vogel JP; Souza JP; Gülmezoglu AM; Winikoff B;
BJOG; 2014 Mar; 121 Suppl 1():5-13. PubMed ID: 24641530
[TBL] [Abstract][Full Text] [Related]
12. Uterotonics for prevention of postpartum haemorrhage: EN-BIRTH multi-country validation study.
Ruysen H; Shabani J; Hanson C; Day LT; Pembe AB; Peven K; Rahman QS; Thakur N; Shirima K; Tahsina T; Gurung R; Tarimo MN; Moran AC; Lawn JE;
BMC Pregnancy Childbirth; 2021 Mar; 21(Suppl 1):230. PubMed ID: 33765962
[TBL] [Abstract][Full Text] [Related]
13. Women's use of non-conventional herbal uterotonic in pregnancy and labour: evidence from birth attendants.
Sumankuuro J; Baatiema L; Crockett J; Young J
BMC Pregnancy Childbirth; 2022 Jul; 22(1):600. PubMed ID: 35896986
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Review of Time to Uterotonic Administration and Maternal Outcomes After Postpartum Hemorrhage.
Knoll W; Phelan R; Hopman WM; Ho AM; Cenkowski M; Mizubuti GB; Ghasemlou N; Klar G
J Obstet Gynaecol Can; 2022 May; 44(5):490-495. PubMed ID: 34844004
[TBL] [Abstract][Full Text] [Related]
15. Oxytocin for preventing postpartum haemorrhage (PPH) in non-facility birth settings.
Pantoja T; Abalos E; Chapman E; Vera C; Serrano VP
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011491. PubMed ID: 27078125
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage.
Lawrie TA; Rogozińska E; Sobiesuo P; Vogel JP; Ternent L; Oladapo OT
Int J Gynaecol Obstet; 2019 Jul; 146(1):56-64. PubMed ID: 31049950
[TBL] [Abstract][Full Text] [Related]
17. Carbetocin for preventing postpartum haemorrhage.
Su LL; Chong YS; Samuel M
Cochrane Database Syst Rev; 2012 Feb; (2):CD005457. PubMed ID: 22336812
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of inhaled oxytocin for prevention of postpartum haemorrhage: a modelling study applied to two high burden settings.
Carvalho N; Hoque ME; Oliver VL; Byrne A; Kermode M; Lambert P; McIntosh MP; Morgan A
BMC Med; 2020 Jul; 18(1):201. PubMed ID: 32718336
[TBL] [Abstract][Full Text] [Related]
19. Cost of hospital care of women with postpartum haemorrhage in India, Kenya, Nigeria and Uganda: a financial case for improved prevention.
Theunissen F; Cleps I; Goudar S; Qureshi Z; Owa OO; Mugerwa K; Piaggio G; Gülmezoglu AM; Nakalembe M; Byamugisha J; Osoti A; Mandeep S; Poriot T; Gwako G; Vernekar S; Widmer M
Reprod Health; 2021 Jan; 18(1):18. PubMed ID: 33482858
[TBL] [Abstract][Full Text] [Related]
20. Poor-quality antimalarials further health inequities in Uganda.
Evans DR; Higgins CR; Laing SK; Awor P; Ozawa S
Health Policy Plan; 2019 Dec; 34(Supplement_3):iii36-iii47. PubMed ID: 31816072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
